Results 161 to 170 of about 9,447 (241)

Advancements in Hydrazide-Based HDAC Inhibitors: A Review of Recent Developments and Therapeutic Potential. [PDF]

J Med Chem
Raucci A, Zwergel C, Valente S, Mai A.
europepmc   +1 more source

Design, synthesis, and evaluation of novel triazole-based carbohydrazide derivatives with notable antioxidant activity: an integrated experimental and DFT study. [PDF]

BMC Chem
Rewish NM, Elmorsy MR, Fadda AA, Badawy SA.   +3 more
europepmc   +1 more source

One-pot synthesis of cinnamoyl hydrazides

ARKIVOC, 2001
Alan R. Katritzky, Mingyi Wang, Suoming Zhang   +2 more
doaj   +1 more source

Discovery of SHANK1-PDZ Peptide-Fragment Inhibitors Using a Dynamic Ligation Screening Strategy. [PDF]

Biochemistry
Li Y, Gimenez D, Warriner SL, Wilson AJ.
europepmc   +1 more source

Polymer Nanomedicines with pH-Triggered Pirarubicin Release: Revealing the Role of Carrier Hydrophilicity and Release Kinetics in Anticancer Performance. [PDF]

Biomacromolecules
Pytlíková S, Jiang B, Woldřichová L, Kotalík K, Androvič L, Gao S, Šubr V, Rumlerová A, Pola R, Podhorská N, Filipová M, Zhang M, Pechar M, Fang J, Laga R, Etrych T.   +15 more
europepmc   +1 more source

Enantioconvergent and diastereoselective synthesis of atropisomeric hydrazides bearing a cyclic quaternary stereocenter through ternary catalysis. [PDF]

Chem Sci
Wang X, Wang SJ, Xin X, An H, Tu Z, Yang H, Wong MW, Lu S.   +7 more
europepmc   +1 more source

Heterochiral coupling to bilateral β-turn structured azapeptides bearing two remote chiral centers. [PDF]

Nat Commun
Yan X, Cao J, Luo H, Li Z, Cao Z, Mo Y, Jiang YB.   +6 more
europepmc   +1 more source

Next-Generation HDAC Inhibitors: Advancing Zinc-Binding Group Design for Enhanced Cancer Therapy. [PDF]

Cells
Hawash M.
europepmc   +1 more source

2-Azidobenzaldehyde-Enabled Construction of Quinazoline Derivatives: A Review. [PDF]

Int J Mol Sci
Qiu W, Zhan D, Ma X, Zhang X.
europepmc   +1 more source

Promising Norlabdane-Heterocyclic Hybrids: Synthesis, Structural Characterization and Antimicrobial Activity Evaluation. [PDF]

Pharmaceuticals (Basel)
Lungu L, Ciocarlan A, Mangalagiu II, Aricu A.   +3 more
europepmc   +1 more source